Home > News > Tagging Faulty Genes with Fluorescent Nanodots
March 9th, 2004
Tagging Faulty Genes with Fluorescent Nanodots
A nanoscale imaging technique that could improve the reliability of an important diagnostic test for breast cancer, and other biomedical tests, is described by National Institute of Standards and Technology (NIST) researchers in the Feb. 11 online issue of Nucleic Acids Research.
Single-Cell Transfection Tool Enables Added Control for Biological Studies: McCormick researchers develop method of delivering molecules into targeted cells May 22nd, 2013
How Gold Nanoparticles Can Help Fight Ovarian Cancer May 21st, 2013
MU Researchers Develop Radioactive Nanoparticles that Target Cancer Cells: This is an early step toward developing therapies for metastasized cancers, MU scientist says May 21st, 2013
Elsevier Business Intelligence (EBI) to Host 'IN3 Medical Device 360 Boston,' June 24-26, 2013 May 20th, 2013